TP53 and colorectal cancer: We used osteosarcoma U2OS cells in vitro and patients with colorectal cancer in silico in our screening because U2OS cells are suitable for the study of p53 signaling and there is sufficient data for a number of patients associated with p53 mutational status in colorectal cancer available in the GEO database for technical issues.